Microbial aetiology of community-acquired pneumonia in hospitalised adults: A prospective study utilising comprehensive molecular testing

•Prospective study on CAP microbial aetiology.•Hospitalised adults with CAP gave LRT samples in the ED.•A pathogen of clinical significance was identified in 81% of CAP patients.•Haemophilus influenzae and SARS-CoV-2 were the most prevalent pathogens.•The Filmarray pneumonia panel increased detectio...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of infectious diseases Vol. 143; p. 107019
Main Authors Markussen, Dagfinn Lunde, Kommedal, Øyvind, Knoop, Siri Tandberg, Ebbesen, Marit Helen, Bjørneklett, Rune Oskar, Ritz, Christian, Heggelund, Lars, Ulvestad, Elling, Serigstad, Sondre, Grewal, Harleen M.S.
Format Journal Article
LanguageEnglish
Published Canada Elsevier Ltd 01.06.2024
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:•Prospective study on CAP microbial aetiology.•Hospitalised adults with CAP gave LRT samples in the ED.•A pathogen of clinical significance was identified in 81% of CAP patients.•Haemophilus influenzae and SARS-CoV-2 were the most prevalent pathogens.•The Filmarray pneumonia panel increased detection from 63% to 81%. This study aimed to describe the microbial aetiology of community-acquired pneumonia (CAP) in adults admitted to a tertiary care hospital and assess the impact of syndromic polymerase chain reaction (PCR) panels on pathogen detection. Conducted at Haukeland University Hospital, Norway, from September 2020 to April 2023, this prospective study enrolled adults with suspected CAP. We analysed lower respiratory tract samples using both standard-of-care tests and the BIOFIRE® FILMARRAY® Pneumonia Plus Panel (FAP plus). The added value of FAP Plus in enhancing the detection of clinically relevant pathogens, alongside standard-of-care diagnostics, was assessed. Of the 3238 patients screened, 640 met the inclusion criteria, with 384 confirmed to have CAP at discharge. In these patients, pathogens with proven or probable clinical significance were identified in 312 (81.3%) patients. Haemophilus influenzae was the most prevalent pathogen, found in 118 patients (30.7%), followed by SARS-CoV-2 in 74 (19.3%), and Streptococcus pneumoniae in 64 (16.7%). Respiratory viruses were detected in 186 (48.4%) patients. The use of FAP plus improved the pathogen detection rate from 62.8% with standard-of-care methods to 81.3%. Pathogens were identified in 81% of CAP patients, with Haemophilus influenzae and respiratory viruses being the most frequently detected pathogens. The addition of the FAP plus panel, markedly improved pathogen detection rates compared to standard-of-care diagnostics alone. [Display omitted]
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1201-9712
1878-3511
1878-3511
DOI:10.1016/j.ijid.2024.107019